Amol Mujumdar Acquires 60,000 Shares in Goldline Pharma

Amol Laxmikant Mujumdar, Promoter and Managing Director of Goldline Pharmaceutical Ltd, has acquired 60,000 equity shares, representing 0.62% of the total issued and paid-up share capital. The acquisition occurred through open market purchases on August 31, 2026. Following this transaction, Mr. Mujumdar's total shareholding in the company increased to 2,809,988 equity shares, constituting 29.27% of the total issued and paid-up share capital. This disclosure is made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.